nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC22A5—Dactinomycin—testicular cancer	0.285	0.424	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—testicular cancer	0.0869	0.129	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—testicular cancer	0.0605	0.09	CbGbCtD
Cephalexin—ALB—Methotrexate—testicular cancer	0.0515	0.0767	CbGbCtD
Cephalexin—CYP3A4—Ifosfamide—testicular cancer	0.0512	0.0761	CbGbCtD
Cephalexin—CYP2D6—Vinblastine—testicular cancer	0.0427	0.0635	CbGbCtD
Cephalexin—CYP3A4—Vinblastine—testicular cancer	0.0271	0.0404	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—testicular cancer	0.0262	0.039	CbGbCtD
Cephalexin—CYP3A4—Etoposide—testicular cancer	0.0244	0.0364	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—testicular cancer	0.0167	0.0248	CbGbCtD
Cephalexin—Confusional state—Ifosfamide—testicular cancer	0.000809	0.00247	CcSEcCtD
Cephalexin—Immune system disorder—Etoposide—testicular cancer	0.000806	0.00246	CcSEcCtD
Cephalexin—Anaphylactic shock—Ifosfamide—testicular cancer	0.000803	0.00245	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000798	0.00243	CcSEcCtD
Cephalexin—Asthenia—Vinblastine—testicular cancer	0.000798	0.00243	CcSEcCtD
Cephalexin—Nervous system disorder—Ifosfamide—testicular cancer	0.000787	0.0024	CcSEcCtD
Cephalexin—Thrombocytopenia—Ifosfamide—testicular cancer	0.000786	0.0024	CcSEcCtD
Cephalexin—Skin disorder—Ifosfamide—testicular cancer	0.00078	0.00238	CcSEcCtD
Cephalexin—Feeling abnormal—Bleomycin—testicular cancer	0.000774	0.00236	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—testicular cancer	0.000773	0.00236	CcSEcCtD
Cephalexin—Vomiting—Chlorambucil—testicular cancer	0.000772	0.00235	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.000769	0.00235	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000766	0.00234	CcSEcCtD
Cephalexin—Diarrhoea—Vinblastine—testicular cancer	0.000761	0.00232	CcSEcCtD
Cephalexin—Leukopenia—Cisplatin—testicular cancer	0.000759	0.00232	CcSEcCtD
Cephalexin—Fatigue—Dactinomycin—testicular cancer	0.000755	0.0023	CcSEcCtD
Cephalexin—Urticaria—Bleomycin—testicular cancer	0.000746	0.00228	CcSEcCtD
Cephalexin—Body temperature increased—Bleomycin—testicular cancer	0.000743	0.00227	CcSEcCtD
Cephalexin—Dizziness—Vinblastine—testicular cancer	0.000735	0.00224	CcSEcCtD
Cephalexin—Convulsion—Cisplatin—testicular cancer	0.000735	0.00224	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000731	0.00223	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—testicular cancer	0.000723	0.00221	CcSEcCtD
Cephalexin—Feeling abnormal—Dactinomycin—testicular cancer	0.000722	0.0022	CcSEcCtD
Cephalexin—Nausea—Chlorambucil—testicular cancer	0.000721	0.0022	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000717	0.00219	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000716	0.00219	CcSEcCtD
Cephalexin—Vomiting—Vinblastine—testicular cancer	0.000707	0.00216	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—testicular cancer	0.000698	0.00213	CcSEcCtD
Cephalexin—Headache—Vinblastine—testicular cancer	0.000697	0.00213	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000696	0.00212	CcSEcCtD
Cephalexin—Leukopenia—Etoposide—testicular cancer	0.000695	0.00212	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000693	0.00211	CcSEcCtD
Cephalexin—Abdominal pain—Dactinomycin—testicular cancer	0.000693	0.00211	CcSEcCtD
Cephalexin—Body temperature increased—Dactinomycin—testicular cancer	0.000693	0.00211	CcSEcCtD
Cephalexin—Fatigue—Ifosfamide—testicular cancer	0.000692	0.00211	CcSEcCtD
Cephalexin—Anaphylactic shock—Cisplatin—testicular cancer	0.000692	0.00211	CcSEcCtD
Cephalexin—Hypersensitivity—Bleomycin—testicular cancer	0.000692	0.00211	CcSEcCtD
Cephalexin—Nervous system disorder—Cisplatin—testicular cancer	0.000679	0.00207	CcSEcCtD
Cephalexin—Thrombocytopenia—Cisplatin—testicular cancer	0.000678	0.00207	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—testicular cancer	0.000677	0.00207	CcSEcCtD
Cephalexin—Asthenia—Bleomycin—testicular cancer	0.000674	0.00206	CcSEcCtD
Cephalexin—Convulsion—Etoposide—testicular cancer	0.000673	0.00205	CcSEcCtD
Cephalexin—Skin disorder—Cisplatin—testicular cancer	0.000672	0.00205	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—testicular cancer	0.000669	0.00204	CcSEcCtD
Cephalexin—Pruritus—Bleomycin—testicular cancer	0.000665	0.00203	CcSEcCtD
Cephalexin—Feeling abnormal—Ifosfamide—testicular cancer	0.000662	0.00202	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—testicular cancer	0.000661	0.00202	CcSEcCtD
Cephalexin—Nausea—Vinblastine—testicular cancer	0.000661	0.00202	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000657	0.002	CcSEcCtD
Cephalexin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000656	0.002	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—testicular cancer	0.000653	0.00199	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000651	0.00199	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000651	0.00199	CcSEcCtD
Cephalexin—Hypersensitivity—Dactinomycin—testicular cancer	0.000645	0.00197	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—testicular cancer	0.00064	0.00195	CcSEcCtD
Cephalexin—Confusional state—Etoposide—testicular cancer	0.000639	0.00195	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000638	0.00195	CcSEcCtD
Cephalexin—Urticaria—Ifosfamide—testicular cancer	0.000638	0.00195	CcSEcCtD
Cephalexin—Abdominal pain—Ifosfamide—testicular cancer	0.000635	0.00194	CcSEcCtD
Cephalexin—Body temperature increased—Ifosfamide—testicular cancer	0.000635	0.00194	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—testicular cancer	0.000634	0.00193	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—testicular cancer	0.000634	0.00193	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000631	0.00192	CcSEcCtD
Cephalexin—Asthenia—Dactinomycin—testicular cancer	0.000629	0.00192	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—testicular cancer	0.000627	0.00191	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—testicular cancer	0.000624	0.00191	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—testicular cancer	0.000621	0.00189	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—testicular cancer	0.000619	0.00189	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—testicular cancer	0.000616	0.00188	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—testicular cancer	0.000605	0.00184	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000603	0.00184	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000603	0.00184	CcSEcCtD
Cephalexin—Diarrhoea—Dactinomycin—testicular cancer	0.000599	0.00183	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000598	0.00182	CcSEcCtD
Cephalexin—Vomiting—Bleomycin—testicular cancer	0.000597	0.00182	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—testicular cancer	0.000595	0.00182	CcSEcCtD
Cephalexin—Infestation—Methotrexate—testicular cancer	0.000595	0.00182	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—testicular cancer	0.000594	0.00181	CcSEcCtD
Cephalexin—Rash—Bleomycin—testicular cancer	0.000592	0.00181	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—testicular cancer	0.000592	0.00181	CcSEcCtD
Cephalexin—Dermatitis—Bleomycin—testicular cancer	0.000592	0.00181	CcSEcCtD
Cephalexin—Hypersensitivity—Ifosfamide—testicular cancer	0.000591	0.0018	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00059	0.0018	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00059	0.0018	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—testicular cancer	0.000584	0.00178	CcSEcCtD
Cephalexin—Asthenia—Ifosfamide—testicular cancer	0.000576	0.00176	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—testicular cancer	0.000573	0.00175	CcSEcCtD
Cephalexin—Feeling abnormal—Cisplatin—testicular cancer	0.00057	0.00174	CcSEcCtD
Cephalexin—Pruritus—Ifosfamide—testicular cancer	0.000568	0.00173	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000563	0.00172	CcSEcCtD
Cephalexin—Nausea—Bleomycin—testicular cancer	0.000558	0.0017	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—testicular cancer	0.000557	0.0017	CcSEcCtD
Cephalexin—Infestation—Epirubicin—testicular cancer	0.000557	0.0017	CcSEcCtD
Cephalexin—Vomiting—Dactinomycin—testicular cancer	0.000557	0.0017	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—testicular cancer	0.000556	0.0017	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000552	0.00169	CcSEcCtD
Cephalexin—Rash—Dactinomycin—testicular cancer	0.000552	0.00169	CcSEcCtD
Cephalexin—Diarrhoea—Ifosfamide—testicular cancer	0.000549	0.00168	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—testicular cancer	0.000549	0.00168	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000547	0.00167	CcSEcCtD
Cephalexin—Body temperature increased—Cisplatin—testicular cancer	0.000547	0.00167	CcSEcCtD
Cephalexin—Fatigue—Etoposide—testicular cancer	0.000547	0.00167	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—testicular cancer	0.000541	0.00165	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—testicular cancer	0.000537	0.00164	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—testicular cancer	0.000535	0.00163	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—testicular cancer	0.000535	0.00163	CcSEcCtD
Cephalexin—Dizziness—Ifosfamide—testicular cancer	0.000531	0.00162	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—testicular cancer	0.000528	0.00161	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000527	0.00161	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—testicular cancer	0.000524	0.0016	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—testicular cancer	0.000522	0.00159	CcSEcCtD
Cephalexin—Nausea—Dactinomycin—testicular cancer	0.00052	0.00159	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—testicular cancer	0.00052	0.00159	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—testicular cancer	0.000518	0.00158	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—testicular cancer	0.000516	0.00157	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—testicular cancer	0.000516	0.00157	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000511	0.00156	CcSEcCtD
Cephalexin—Vomiting—Ifosfamide—testicular cancer	0.00051	0.00156	CcSEcCtD
Cephalexin—Hypersensitivity—Cisplatin—testicular cancer	0.00051	0.00156	CcSEcCtD
Cephalexin—Rash—Ifosfamide—testicular cancer	0.000506	0.00154	CcSEcCtD
Cephalexin—Dermatitis—Ifosfamide—testicular cancer	0.000506	0.00154	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—testicular cancer	0.000505	0.00154	CcSEcCtD
Cephalexin—Urticaria—Etoposide—testicular cancer	0.000504	0.00154	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—testicular cancer	0.000503	0.00153	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—testicular cancer	0.000501	0.00153	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—testicular cancer	0.000501	0.00153	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—testicular cancer	0.0005	0.00153	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—testicular cancer	0.0005	0.00153	CcSEcCtD
Cephalexin—Asthenia—Cisplatin—testicular cancer	0.000497	0.00151	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—testicular cancer	0.000494	0.00151	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—testicular cancer	0.000492	0.0015	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—testicular cancer	0.00049	0.0015	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000488	0.00149	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—testicular cancer	0.000483	0.00147	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—testicular cancer	0.000481	0.00147	CcSEcCtD
Cephalexin—Nausea—Ifosfamide—testicular cancer	0.000477	0.00145	CcSEcCtD
Cephalexin—Diarrhoea—Cisplatin—testicular cancer	0.000474	0.00144	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—testicular cancer	0.000473	0.00144	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—testicular cancer	0.000468	0.00143	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—testicular cancer	0.000467	0.00143	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—testicular cancer	0.000465	0.00142	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—testicular cancer	0.000463	0.00141	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—testicular cancer	0.000463	0.00141	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000457	0.00139	CcSEcCtD
Cephalexin—Asthenia—Etoposide—testicular cancer	0.000455	0.00139	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000455	0.00139	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—testicular cancer	0.000454	0.00138	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—testicular cancer	0.000452	0.00138	CcSEcCtD
Cephalexin—Pruritus—Etoposide—testicular cancer	0.000449	0.00137	CcSEcCtD
Cephalexin—Vomiting—Cisplatin—testicular cancer	0.00044	0.00134	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—testicular cancer	0.000438	0.00134	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—testicular cancer	0.000438	0.00134	CcSEcCtD
Cephalexin—Rash—Cisplatin—testicular cancer	0.000436	0.00133	CcSEcCtD
Cephalexin—Dermatitis—Cisplatin—testicular cancer	0.000436	0.00133	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—testicular cancer	0.000434	0.00132	CcSEcCtD
Cephalexin—Dizziness—Etoposide—testicular cancer	0.000419	0.00128	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—testicular cancer	0.000418	0.00128	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—testicular cancer	0.000417	0.00127	CcSEcCtD
Cephalexin—Nausea—Cisplatin—testicular cancer	0.000411	0.00125	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—testicular cancer	0.000406	0.00124	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—testicular cancer	0.000403	0.00123	CcSEcCtD
Cephalexin—Vomiting—Etoposide—testicular cancer	0.000403	0.00123	CcSEcCtD
Cephalexin—Agitation—Epirubicin—testicular cancer	0.0004	0.00122	CcSEcCtD
Cephalexin—Rash—Etoposide—testicular cancer	0.0004	0.00122	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—testicular cancer	0.000399	0.00122	CcSEcCtD
Cephalexin—Headache—Etoposide—testicular cancer	0.000397	0.00121	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—testicular cancer	0.000396	0.00121	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000393	0.0012	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—testicular cancer	0.00039	0.00119	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—testicular cancer	0.000383	0.00117	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—testicular cancer	0.00038	0.00116	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—testicular cancer	0.000377	0.00115	CcSEcCtD
Cephalexin—Nausea—Etoposide—testicular cancer	0.000377	0.00115	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—testicular cancer	0.000372	0.00114	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—testicular cancer	0.000372	0.00113	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—testicular cancer	0.000371	0.00113	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—testicular cancer	0.00037	0.00113	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—testicular cancer	0.000369	0.00113	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000368	0.00112	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—testicular cancer	0.000361	0.0011	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—testicular cancer	0.000358	0.00109	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—testicular cancer	0.000355	0.00108	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—testicular cancer	0.000349	0.00107	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—testicular cancer	0.000349	0.00106	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—testicular cancer	0.000348	0.00106	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000346	0.00106	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—testicular cancer	0.000345	0.00105	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—testicular cancer	0.000343	0.00105	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000341	0.00104	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—testicular cancer	0.000334	0.00102	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—testicular cancer	0.000332	0.00101	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000329	0.001	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000328	0.001	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—testicular cancer	0.000327	0.000999	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000324	0.000988	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—testicular cancer	0.000323	0.000984	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000322	0.000982	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—testicular cancer	0.000319	0.000974	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—testicular cancer	0.000313	0.000955	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—testicular cancer	0.000313	0.000954	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000311	0.000947	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000307	0.000936	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—testicular cancer	0.000306	0.000935	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—testicular cancer	0.000302	0.00092	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—testicular cancer	0.0003	0.000916	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—testicular cancer	0.0003	0.000916	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.0003	0.000914	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—testicular cancer	0.000293	0.000893	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000291	0.000887	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—testicular cancer	0.000289	0.000883	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000284	0.000866	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—testicular cancer	0.000284	0.000865	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—testicular cancer	0.000282	0.000861	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—testicular cancer	0.000281	0.000857	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—testicular cancer	0.000281	0.000857	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—testicular cancer	0.00028	0.000854	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—testicular cancer	0.000272	0.000831	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—testicular cancer	0.000271	0.000827	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000269	0.00082	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—testicular cancer	0.000269	0.00082	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—testicular cancer	0.000262	0.000799	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—testicular cancer	0.000261	0.000797	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—testicular cancer	0.00026	0.000793	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—testicular cancer	0.00026	0.000793	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—testicular cancer	0.00026	0.000793	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—testicular cancer	0.000255	0.000778	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—testicular cancer	0.000251	0.000767	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—testicular cancer	0.000251	0.000766	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—testicular cancer	0.000243	0.000742	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—testicular cancer	0.000242	0.000739	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—testicular cancer	0.000241	0.000737	CcSEcCtD
Cephalexin—Rash—Methotrexate—testicular cancer	0.000239	0.000731	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—testicular cancer	0.000239	0.00073	CcSEcCtD
Cephalexin—Headache—Methotrexate—testicular cancer	0.000238	0.000726	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—testicular cancer	0.000236	0.00072	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—testicular cancer	0.000235	0.000717	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—testicular cancer	0.000233	0.00071	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—testicular cancer	0.000226	0.000689	CcSEcCtD
Cephalexin—Nausea—Methotrexate—testicular cancer	0.000226	0.000688	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—testicular cancer	0.000225	0.000686	CcSEcCtD
Cephalexin—Rash—Epirubicin—testicular cancer	0.000224	0.000684	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—testicular cancer	0.000224	0.000683	CcSEcCtD
Cephalexin—Headache—Epirubicin—testicular cancer	0.000223	0.000679	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—testicular cancer	0.000217	0.000663	CcSEcCtD
Cephalexin—Nausea—Epirubicin—testicular cancer	0.000211	0.000644	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—testicular cancer	0.000209	0.000638	CcSEcCtD
Cephalexin—Rash—Doxorubicin—testicular cancer	0.000207	0.000633	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—testicular cancer	0.000207	0.000632	CcSEcCtD
Cephalexin—Headache—Doxorubicin—testicular cancer	0.000206	0.000628	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—testicular cancer	0.000195	0.000596	CcSEcCtD
